Prescription medicine spending in US may hit US$610b by 2021: report
New York
SPENDING on prescription medicines in the US will increase 4-7 per cent through 2021, reaching US$580 billion to US$610 billion, according to a report released by QuintilesIMS Holding on Thursday that lowered its prior long-term forecast.
QuintilesIMS, which compiles data for the pharmaceutical industry, had previously forecast average spending growth of 6-9 per cent through 2021. It reduced its projections due to fewer new medicines approved in 2016 than prior years and as drugmakers face increasing pricing pressure and competition.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Starbucks points to weaker consumer as profit falls
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability
Coca-Cola raises annual sales forecast on global demand, higher prices
Dying salmon trouble Norway’s vast fish-farm industry
Fast-fashion giant Shein wants to sell skincare, toothpaste and toys, too